The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective
Chronic Kidney Disease (CKD) is a highly prevalent disease with a substantial medical need for new and more efficacious treatments. The Nitric Oxide (NO), soluble guanylyl cyclase (sGC), cyclic guanosine monophosphate (cGMP) signaling cascade regulates various kidney functions. cGMP directly influen...
Main Authors: | Shalini M. Krishnan, Jan R. Kraehling, Frank Eitner, Agnès Bénardeau, Peter Sandner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/6/1712 |
Similar Items
-
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
by: Susana S. Correia, et al.
Published: (2021-09-01) -
Σύνθεση, αποτίμηση και μελέτη της σχέσης χημικής δομής βιολογικής δραστικότητας στο καρδιαγγειακό σύστημα, νέων τετραϋδροϊνδολικών παραγώγων
by: Σπυριδωνίδου, Κατερίνα
Published: (2010) -
The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases
by: Susana S. Correia, et al.
Published: (2021-05-01) -
Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway
by: Daniel Fleischmann, et al.
Published: (2021-03-01) -
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator
by: Detmar Kolijn, et al.
Published: (2020-05-01)